Back
Cara Therapeutics Stock Price Chart
Sponsored
CARA
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
CARA
Cara Therapeutics
Last Price:
$0.44
Seasonality Move:
-5.48%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.35 | Buy |
20-day SMA: | 0.31 | Buy |
50-day SMA: | 0.3 | Buy |
200-day SMA: | 0.46 | Buy |
8-day EMA: | 0.38 | Buy |
20-day EMA: | 0.33 | Buy |
50-day EMA: | 0.31 | Buy |
200-day EMA: | 0.62 | Sell |
Cara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 79.45 | Buy |
Chaikin Money Flow: | 852669 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.25 - 0.37) | Buy |
Bollinger Bands (100): | (0.27 - 0.35) | Buy |
Cara Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cara Therapeutics Stock
Is Cara Therapeutics Stock a Buy?
-
Cara Therapeutics share price is 0.46 while CARA 8-day simple moving average is 0.35, which is a Buy signal.
-
The stock price of CARA is 0.46 while Cara Therapeutics 20-day SMA is 0.31, which makes it a Buy.
-
Cara Therapeutics 50-day simple moving average is 0.30 while CARA share price is 0.46, making it a Buy technically.
-
CARA stock price is 0.46 and Cara Therapeutics 200-day simple moving average is 0.46, creating a Buy signal.
CARA Technical Analysis vs Fundamental Analysis
Sell
38
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy or a Sell?
-
Cara Therapeutics stock is rated a SellThe current Cara Therapeutics [CARA] share price is $0.46. The Score for CARA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Cara Therapeutics Stock Info
Market Cap:
24.2M
Price in USD:
0.46
Share Volume:
1.2M
Cara Therapeutics 52-Week Range
52-Week High:
1.15
52-Week Low:
0.23
Sell
38
Cara Therapeutics (CARA)
is a Sell
Cara Therapeutics Share Price Forecast
-
What is the Cara Therapeutics stock price today?The Cara Therapeutics stock price is 0.46 USD today.
-
Will CARA stock go up or go down?Cara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cara Therapeutics is overvalued.
Is Cara Therapeutics Stock a Buy?
-
Cara Therapeutics share price is 0.46 while CARA 8-day exponential moving average is 0.38, which is a Buy signal.
-
The stock price of CARA is 0.46 while Cara Therapeutics 20-day EMA is 0.33, which makes it a Buy.
-
Cara Therapeutics 50-day exponential moving average is 0.31 while CARA share price is 0.46, making it a Buy technically.
-
CARA stock price is 0.46 and Cara Therapeutics 200-day simple moving average is 0.62, creating a Sell signal.
Fundamental Analysis of Cara Therapeutics
Is Cara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $0.25 per share.
Technical Analysis of Cara Therapeutics
Should I short Cara Therapeutics stock?
-
CARA Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Cara Therapeutics is a Buy
-
Cara Therapeutics Relative Strength Index (RSI) is 79.45, which suggest Cara Therapeutics is overbought
-
The Bollinger Bands (25) for Cara Therapeutics is (0.25 - 0.37), which suggest Cara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cara Therapeutics is (0.27 - 0.35), which suggest Cara Therapeutics is a Buy
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.